Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool February 10, 2009 Dan Caplinger	5 Stocks You'd Be Crazy to Buy Now If your stocks have absolutely nothing going for them, you really owe it to yourself to pull the plug and move on -- no matter how painful it may be.
The Motley Fool October 22, 2010 Anand Chokkavelu	7 Big Pharma Stocks Near 52-Week Lows Trolling the bottom for upside potential.
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space.
The Motley Fool September 9, 2010 Jim Mueller	Today's Buy Opportunity: Teva Pharmaceutical Take advantage of this growing generic-drug maker.
The Motley Fool May 9, 2011 Anand Chokkavelu	Rising Star Buy: National Presto National Presto, appliance and ammunition maker, pays out a small, regular dividend each year, equating to a 0.9% dividend yield at today's prices. But counting its special dividend, that yield jumps to 7.4%.
The Motley Fool November 7, 2011 Dan Caplinger	Has Pfizer Become the Perfect Stock? The pharma giant still faces the challenge of patent expirations that could outpace its pipeline development.
The Motley Fool June 30, 2011 Matt Koppenheffer	Could National Presto Double Your Money? Is it high time to add this stock to your portfolio?
The Motley Fool January 10, 2007 John Reeves	Is Your Stock a Dog? A dividend yield can be a very misleading ratio, and when it comes to identifying stable companies that deliver regular and growing cash flows, you must look deeper than just a single metric.
The Motley Fool June 10, 2011 Matt Koppenheffer	Could Teva Pharmaceutical Score You 100% Returns? Is it high time to add Teva's stock to your portfolio?
The Motley Fool December 8, 2011 Brendan Byrnes	Another Reason to Buy Ford Now Ford delivers a dividend, and its stock gets cheaper?
The Motley Fool May 31, 2007 Ryan Fuhrmann	Dueling Fools: Eli Lilly Bull Thanks to a couple of recent developments and a focus on research & development, the pharma giant is a worthy contender for health-care exposure in investors' portfolios.
The Motley Fool February 22, 2005 Charly Travers	Is Big Pharma a Bargain? While much of the drug sector is looking pretty tasty, Pfizer, with its attractive relative valuation, dominant marketing presence, and willingness to buy up blockbuster drugs, heads the list.
The Motley Fool August 6, 2011 Sean Williams	10 Large Caps to Rule Them All There's nothing generic about this company. For the inaugural large-cap pick, I think we should revisit pharma's most impervious pipeline, Teva Pharmaceuticals.
The Motley Fool April 5, 2005 Selena Maranjian	Don't Be a Simple-Minded Investor One mistake that many beginning investors (and some seasoned investors, as well) make is to put too much stock in one or a few measures as they evaluate companies as possible investments.
The Motley Fool November 25, 2011 Dan Caplinger	Has Merck Become the Perfect Stock? Like most other pharma companies, Merck is dealing with the imminent loss of patent protection on one of its blockbuster drugs.
The Motley Fool July 30, 2010 Anand Chokkavelu	The 7 Biggest, Baddest Dividend Stocks Out There The names may surprise you.
The Motley Fool December 30, 2010 Anand Chokkavelu	4 Automotive Stocks Near 52-Week Lows These are the top four companies in the automotive space (by market cap) that are hugging 52-week lows: General Motors... China Automotive Systems... Wonder Auto Technology... China XD Plastics...
The Motley Fool December 22, 2010 Stephen J. Marini	Are These High-Yield Stocks Too Good to Be True? Look deep into the numbers on high yielders to avoid dividend traps.
The Motley Fool July 22, 2011 Matt Koppenheffer	Could Eli Lilly's Stock Double Your Money? With concerns swirling around the big pharma companies, could it be time to buy Eli Lilly?
The Motley Fool January 12, 2006 Tim Beyers	Kerkorian Takes GM Off-Road The billionaire investor finally suggests the inevitable: while the dividend is the least of GM's problems, it's one that needs to go away -- now -- if bankruptcy is to be avoided. Investors, take note.
The Motley Fool December 13, 2011 Brian Orelli	Dividend? Buyback? Here's How to Get Both. But will there be enough to replenish the pipeline?
The Motley Fool October 5, 2011 Dan Caplinger	Has Teva Pharmaceutical Become the Perfect Stock? Teva still looks poised to stay near perfection for the indefinite future.
The Motley Fool December 11, 2011 Anand Chokkavelu	5 Stocks to Buy in 2012 Getting a jump start on the year ahead with stocks like Corning and Ford.
The Motley Fool November 10, 2010 Selena Maranjian	Get Your Big Yields the Right Way Some "income funds" offer less income than you'd think.
The Motley Fool April 22, 2005 David Meier	GMAC: The Golden Goose Should investors take a chance?
The Motley Fool November 29, 2011 Dan Caplinger	Has Eli Lilly Become the Perfect Stock? The reason Lilly offers such an attractive yield and cheap valuation is that investors aren't sure it can keep up its past success.
The Motley Fool January 18, 2011 Russ Krull	Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold?
The Motley Fool February 7, 2006 W.D. Crotty	GM Going Into Crisis Mode GM appoints Jerome York to its board and cuts its dividend. For now, the auto maker appears to be on the right path. But for investors, the stock is still a speculative investment
The Motley Fool August 15, 2008 Anand Chokkavelu	Don't Trust This Yield Want to know whether a company is likely to slash its dividend? All you have to do is answer one question.
The Motley Fool October 30, 2009 Dan Caplinger	Should You Dump These Dividend Stocks? After the market's big rally, many stocks have seen their dividend yields drop sharply. Do those falling yields mean that you should get out of these dividend stocks now before it's too late?
The Motley Fool October 20, 2011 John Reeves	5 Banks That Will Let You Sleep at Night Look to our northern neighbors for some reliable banking investments.
The Motley Fool January 31, 2007 Brian Lawler	Lilly Floats Atop Rivals The large-cap pharma posts slow, steady growth. Investors, take note.
The Motley Fool April 8, 2010 Anand Chokkavelu	It's Time to Jump on These Stocks Consider these stocks before you buy your next stock.
The Motley Fool July 22, 2008 Adam J. Wiederman	Stocks to Get You Through the Bear Market You do want to survive, right?
The Motley Fool November 28, 2011 Dan Caplinger	Has Best Buy Become the Perfect Stock? If Best Buy can compete successfully with Amazon, there's an awful lot of upside for shareholders in the long run.
The Motley Fool January 13, 2005 Selena Maranjian	Big Dividend Payers Big dividend payers can reward you well, but select carefully.
The Motley Fool March 31, 2011 Todd Wenning	Dividend Sector Review: Pharmaceuticals These pharmaceutical stocks generate an adequate amount of free cash flow to fund their well above-average dividend yields.
The Motley Fool April 20, 2005 Rich Smith	Pick a Car Company. Any Car Company. There's something for investors to like in all of the major automakers.
The Motley Fool July 2, 2010 Gerard Torres	Go Canada for Your Banking Buys With a booming economy, Canadian banks are looking like good investments.
The Motley Fool June 30, 2010 Rich Smith	This Just In: Upgrades and Downgrades Major Wall Street investment house Soleil Securities downgraded Eli Lilly shares to "sell."
The Motley Fool October 30, 2007 Charly Travers	Winners and Losers in Big Pharma Some drugmakers are hitting a slump, but not all of them. Which ones can still cure what ails your portfolio?
The Motley Fool August 10, 2010 Jim Mueller	3 Beaten-Down Dividend Payers A look at three companies that might deserve a spot in your portfolio.
The Motley Fool January 26, 2006 W.D. Crotty	GM's Giant Miss General Motors reports a massive third-quarter loss. The automaker faces formidable competition that lacks difficulties like a poor credit rating, an unearned dividend, and an inability to lucidly articulate capital expenditures and other major expenses.
The Motley Fool September 25, 2008 Brian Orelli	Teva Heads to Japan It's conquering the world, slowly but surely. But is it still a value play?
The Motley Fool December 17, 2009 Rich Smith	This Just In: Upgrades and Downgrades Big Pharma stocks get a thumbs up from UBS.
The Motley Fool August 13, 2010 Ilan Moscovitz	Merck: Dividend Dynamo or Disaster? Just how safe is this dividend?
The Motley Fool April 17, 2007 Ryan Fuhrmann	Clean Bill of Health at Eli Lilly Lilly recorded another solid quarter, but its valuation is a little rich.
The Motley Fool January 31, 2011 Morgan Housel	10 Core Stocks: A Microsoft Update Mr. Softy's still looking bright.
The Motley Fool August 29, 2008 Brian Orelli	Can Health-Care Dividends Hold Up? As many health-care companies' share prices drop, their dividend yields have become strikingly attractive. The big question, though, is whether these dividends can hold up.
The Motley Fool June 7, 2010 Selena Maranjian	I'm Resisting This Irresistible Bargain It's hard not to consider BP as a possible addition to your portfolio these days, since the stock has fallen 30% to 40%, but you might get burned.